Cargando…
Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response
BACKGROUND: Cantharidin (CTD) is a major ingredient of cantharis (Mylabris phalerata Pallas) and has been used extensively in traditional Chinese medicines. It has been shown to exhibit anticancer activity in multiple types of cancer, especially hepatocellular carcinoma (HCC). However, there is no s...
Autores principales: | Yan, Jia, Deng, Xiu ling, Ma, Shi qi, hui Li, Yu, Gao, Yu min, Shi, Gui tao, Wang, Hai sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193799/ https://www.ncbi.nlm.nih.gov/pubmed/37202806 http://dx.doi.org/10.1186/s12906-023-03975-0 |
Ejemplares similares
-
Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma
por: Yan, Jia, et al.
Publicado: (2023) -
EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
por: Sun, Si, et al.
Publicado: (2020) -
EZH2-mediated H3K27me3 inhibits ACE2 expression
por: Li, Yuanyuan, et al.
Publicado: (2020) -
The EZH2–PRC2–H3K27me3 axis governs the endometrial cell cycle and differentiation for blastocyst invasion
por: Fukui, Yamato, et al.
Publicado: (2023) -
EZH2-Mediated H3K27me3 Targets Transcriptional Circuits of Neuronal Differentiation
por: Buontempo, Serena, et al.
Publicado: (2022)